Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
SpotitEarly · with Hackensack Meridian Health, University of Pennsylvania · NCT07038785
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1204
- US sites recruiting
- 2
- Study start
- July 22, 2025
- Record last updated
- May 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biopsy for a possible cancer, will be invited to take part. Participants will be asked to breathe into a surgical mask to collect a breath sample.
The mask will be sent to a special laboratory, where trained dogs and an AI-based system will check the sample for signs of breast cancer. The results from the dogs and AI will be compared to the actual results from the medical screening or biopsy to see how accurate the system is at detecting breast cancer.
Being studied: Breath test
Conditions: Breast Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
INCLUSION CRITERIA FOR ARM 1 (TARGET POPULATION ARM)
- Capable of giving informed consent for self, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
- Assigned female at birth.
- 40 years of age and above OR
- Between 18 and 39 years of age (inclusive) and a carrier of germline pathogenic variants associated with high risk for breast cancer: BRCA1, BRCA2, PTEN, TP53, CDH1, or STK11 ATM, CHEK2, BARD1, RAD51D, RAD51C, PALB2, OR
- Between 18 and 39 years of age (inclusive) with a family history of breast or ovarian cancer involving at least one first or two second-degree relatives who were diagnosed with breast or ovarian cancer before the age of 50 years.
- Scheduled for routine annual breast cancer screening (Mammogram, Ultrasound and MRI)
INCLUSION CRITERIA FOR ARM 2 (ENRICHED ARM)
- Capable of giving informed consent for self, which includes compliance with the requirements and restrictions listed in the ICF and in this protocol.
- Assigned female at birth.
- 40 years of age and above. OR
- Between 18 and 39 years of age (inclusive) and a carrier of germline pathogenic variants associated with high risk for breast cancer: BRCA1, BRCA2, PTEN, TP53, CDH1, or STK11 ATM, CHEK2, BARD1, RAD51D, RAD51C, PTEN , PALB2 OR
- Between 18 and 30 years of age (inclusive) with a family history of breast or ovarian cancer involving at least one first or two second-degree relatives who were diagnosed with breast or ovarian cancer before the age of 35 years.
- BI-RADS® score of 4B.
- Scheduled for breast biopsy.
EXCLUSION CRITERIA (BOTH STUDY ARMS)
- Had cancer within the past year. Individuals who underwent surgical removal of cancerous non-metastatic skin lesions can be recruited.
- Has received any cancer treatments within the past year.
- Has participated in another clinical study in the past 30 days.
- Had bilateral mastectomy for breast cancer or for preventive reasons related to breast cancer.
- Had a medical procedure in the chest cavity and/or airways within the past 2 weeks which may interfere with the ability to provide a normal breath sample as required by the protocol.
Recruiting US locations
Hackensack Meridian Health
Totowa, NJ 07512
Site contact: Lee Ifhar, MSc, CCRP · 551-215-0508 · Lee.ifhar@hmhn.org
Hospital of the University of Pennsylvania
Philadelphia, PA 19104
Site contact: Autumn Winch, BS · 445-273-2715 · Autumn.Winch@pennmedicine.upenn.edu
Study contacts (from the official record)
- Udi Bobrovsky · +972-54-456-0008 · udi@spotitearly.com
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55